CC BY-NC-ND 4.0 · Laryngorhinootologie 2020; 99(S 02): S163
DOI: 10.1055/s-0040-1711024
Abstracts
Oncology

Devising novel imaging biomarkers for Human Papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma (OPSCC): applying radiomics and machine learning algorithms

Stefan Philipp Haider
1   Yale School of Medicine, Department of Radiology and Biomedical Imaging New Haven United States
,
A Mahajan
1   Yale School of Medicine, Department of Radiology and Biomedical Imaging New Haven United States
,
T Zeevi
1   Yale School of Medicine, Department of Radiology and Biomedical Imaging New Haven United States
,
R Forghani
3   McGill University, Department of Diagnostic Radiology Montreal Canada
,
B Kann
4   Harvard Medical School, Dana-Farber Cancer Institute, Radiation Oncology Boston United States
,
BL. Judson
5   Yale School of Medicine, Department of Surgery New Haven United States
,
B Burtness
6   Yale School of Medicine, Department of Internal Medicine New Haven United States
,
K Sharaf
2   Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde München
,
C Reichel
2   Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde München
,
P Baumeister
2   Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde München
,
S Payabvash
1   Yale School of Medicine, Department of Radiology and Biomedical Imaging New Haven United States
› Author Affiliations
 

Purpose HPV-positive and HPV-negative OPSCC are biologically distinct entities, with different prognosis and divergent AJCC/UICC staging schemes. Radiomics refers to automated extraction of shape, intensity and texture features from target lesions on medical images – inaccessible to visual interpretation. We applied machine learning classifiers to devise radiomics signatures to determine the HPV-status in OPSCC.

Methods Imaging data was retrieved form The Cancer Imaging Archive and our institutional archives. Patients with OPSCC, known HPV/p16-status, and pre-treatment FDG‑PET / non‑contrast CT were included.

The primary tumors were delineated on PET and CT scans. 1040 radiomics features describing texture, shape and signal intensity characteristics were extracted from each tumor and per imaging modality.

For HPV-status prediction, LASSO regression feature selection (LASSO) and random forest (RF) machine learning classifiers were applied in 10-fold cross validation, repeated 10x. The area under the receiver operating characteristic curve (AUC-ROC) averaged across validation folds is reported.

Conclusions A total of 244 HPV-positive and 82 HPV-negative OPSCC patients were included: 46 T1, 119 T2, 107 T3, and 54 T4 UICC/AJCC stage primary tumors were analyzed. The LASSO / RF machine learning algorithm achieved an averaged AUC-ROC of 0.79 (PET/CT), 0.74 (CT) and 0.70 (PET).

Conclusion Radiomics feature extraction from PET and CT scans, combined with machine learning classifiers can generate imaging biomarkers for HPV in OPSCC primary tumors, which may aid in HPV-classification if standard immunohistochemical staining is equivocal, or supplement the immunohistochemical tests in subjects requiring second-line testing.

Poster-PDF A-1164.PDF



Publication History

Article published online:
10 June 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

© Georg Thieme Verlag KG
Stuttgart · New York